Annual Drug Patent Expirations for GADAVIST Gadavist is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Bayer Hlthcare drug GADAVIST appeared first…
New patent expiration for Bayer Hlthcare drug GADAVIST Read Post »
Annual Drug Patent Expirations for SAVELLA Savella is a drug marketed by Allergan and is included in one NDA. It is available from three suppliers. There are four patents protecting…
The post New patent expiration for Allergan drug SAVELLA appeared fir…
INBRIJA (levodopa) Acorda Patent: 7,556,798 Expiration: Nov 4, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Patent E…
Drug Patent Expirations for the Week of October 31, 2021 Read Post »
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are thirteen patents protecting…
The post New patent expiration for Acorda drug INBRIJA appeared first …
Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent expiration for Alkermes Inc drug LYBALVI appeared first on …
New patent expiration for Alkermes Inc drug LYBALVI Read Post »
Annual Drug Patent Expirations for HYSINGLA+ER Hysingla Er is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Purdue Pharma drug HYSINGLA ER appeared first…
New patent expiration for Purdue Pharma drug HYSINGLA ER Read Post »
GRALISE (gabapentin) Almatica Patent: 6,723,340 Expiration: Oct 25, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of October 24, 2021 Read Post »
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. There are eighteen patents protecting this drug. Drug patent litigation…
The post New patent expiration for Alexza Pharms drug ADASUVE ap…
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
Annual Drug Patent Expirations for GLUMETZA Glumetza is a drug marketed by Santarus Inc and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Santarus Inc drug GLUMETZA appeared firs…
New patent expiration for Santarus Inc drug GLUMETZA Read Post »
Annual Drug Patent Expirations for INVOKAMET+XR Invokamet Xr is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are six…
The post New patent expiration for Janssen Pharms drug INVOKAMET XR appeared…
New patent expiration for Janssen Pharms drug INVOKAMET XR Read Post »